Article info
PDFReview
CCM3 and cerebral cavernous malformation disease
- Correspondence to Dr Min Wang, Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology Yale University School of Medicine New Haven Connecticut USA; wang.min{at}yale.edu
Citation
CCM3 and cerebral cavernous malformation disease
Publication history
- Received October 19, 2018
- Revised January 22, 2019
- Accepted February 12, 2019
- First published March 2, 2019.
Online issue publication
May 01, 2020
Article Versions
- Previous version (4 July 2019).
- Previous version (4 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.